Skip to main content

Table 1 Meta-analysis results of AEs

From: Clinical translation of stem cell therapy for spinal cord injury still premature: results from a single-arm meta-analysis based on 62 clinical trials

AEs

Stem cell types

Number of studies

Incidence

Heterogeneity (I2)

AEs of the nervous system

 Neuropathic pain

Total

20

25.2% [14.2%, 37.8%]

84.514%

BMSCs

17

27.9% [15.1, 42.5]

86.636%

UCMSCs

2

14.0 [2.6, 30.5]

0.0%

NSCs

1

8.3 [0.2, 38.5]

/

 Abnormal feeling

Total

4

24.8% [10.5%, 41.8%]

0.0%

BMSCs

4

24.8% [10.5%, 41.8%]

0.0%

 Fever

Total

18

15.5% [10.0%, 21.8%]

80.528%

BMSCs

9

18.6% [7.1%, 33.2%]

83.669%

UCMSCs

5

11.6% [8.4%, 15.1%]

0.0%

HSCs

3

8.9% [0%, 26.8%]

94.602

ESCs

1

13.2% [8.9%, 18.7%]

/

CBSCs

1

12.0% [2.5%, 31.2%]

/

 Headache

Total

19

13.5% [8.4%, 19.5%]

80.332%

BMSCs

10

16.2% [8.1%, 25.9%]

70.036%

UCMSCs

4

5.5% [0.6%, 13.4%]

44.522%

NSCs

2

19.2% [7.9%, 33.4%]

0.0%

ADMSCs

1

21.4% [4.7%, 50.8%]

/

ESCs

1

11.3% [7.3%, 16.4%]

/

HSCs

1

12.4% [8.2%, 17.7%]

/

 Abnormal autonomic reflexes

Total

1

10.3% [2.2%, 27.4%]

/

NSCs

1

10.3% [2.2%, 27.4%]

/

 Cerebrospinal fluid leak

Total

3

7.7% [1.7%, 16.3%]

0.0%

BMSCs

2

5.8% [0%, 17.4%]

0.0%

NSCs

1

10.3% [2.2%, 27.4%]

/

 Meningismus

Total

1

3.5% [1.4%, 7.0%]

/

HSCs

1

3.5% [1.4%, 7.0%]

/

 Pseudomeningocele

Total

1

3.4% [0.1%, 17.8%]

/

NSCs

1

3.4% [0.1%, 17.8%]

/

 Lethargy

Total

1

2.0% [0.5%, 5.0%]

/

HSCs

1

2.0% [0.5%, 5.0%]

/

 Dizziness

Total

2

1.9% [0.9%, 3.2%]

57.3%

UCMSCs

1

1.3% [0.4%, 3.0%]

/

HSCs

1

3.5% [1.4%, 7.0%]

/

 Mental disorder

Total

2

1.0% [0%, 3.2%]

77.7%

UCMSCs

1

20.0% [5.7%, 43.7%]

/

HSCs

1

1.0% [0.1%, 3.5%]

/

AEs of the musculoskeletal system

 Muscle spasms

Total

11

25.5% [13.2%, 39.8%]

90.162%

BMSCs

8

24.1% [10.5%, 40.6%]

84.328%

UCMSCs

1

24.1% [10.3%, 43.5%]

/

NSCs

1

5.3% [0.1%, 26.0%]

/

HSCs

1

54.5% [47.3, 61.5%]

/

 Increased muscle tone

Total

4

18.8% [0.2%, 51.3%]

92.790%

BMSCs

3

29.8% [12.3%, 50.6%]

52.086%

UCMSCs

1

1.6% [0.6%, 3.4%]

/

 Lower limb muscle atrophy

Total

1

16.7% [0.4%, 64.1%]

/

BMSCs

1

16.7% [0.4%, 64.1%]

/

 Osteoporosis

Total

1

15.0% [3.2%, 37.9%]

/

UCMSCs

1

15.0% [3.2%, 37.9%]

/

 Back pain

Total

1

4.5% [0.1%, 22.8%]

/

UCMSCs

1

4.5% [0.1%, 22.8%]

/

 Seizures

Total

1

3.4% [0.1%, 17.8%]

/

NSCs

1

3.4% [0.1%, 17.8%]

/

AEs of the digestive system

 Vomit

Total

3

21.6% [8.9%, 37.2%]

0.0%

BMSCs

1

23.1% [5.0%, 53.8%]

/

ADMSCs

1

21.4% [4.7%, 50.8%]

/

UCMSCs

1

20.0% [2.5%, 55.6%]

/

 Gastrointestinal dysfunction

Total

4

10.8% [0.1%, 31.5%]

90.061%

BMSCs

2

14.3% [5.7%, 25.6%]

0.0%

UCMSCs

1

30.0% [11.9%, 54.3%]

/

ESCs

1

1.0% [0.1%, 3.5%]

/

 Nausea

Total

2

0.5% [0%, 2.5%]

71.1%

ADMSCs

1

21.4% [4.7%, 50.8%]

/

ESCs

1

1.0% [0.1%, 3.5%]

/

AEs of the cardiovascular system

 Hypertension

Total

2

12.7% [8.7%, 17.3%]

61.1%

BMSCs

1

7.0% [1.5%, 19.1%]

/

HSCs

1

14.4% [9.8%, 20.0%]

/

 Low blood pressure

Total

1

5.9% [3.1%, 10.1%]

/

HSCs

1

5.9% [3.1%, 10.1%]

/

 Deep vein thrombosis

Total

1

5.0% [0.1%, 24.9%]

/

UCMSCs

1

5.0% [0.1%, 24.9%]

/

 Postoperative sepsis

Total

1

3.4% [0.1%, 17.8%]

/

NSCs

1

3.4% [0.1%, 17.8%]

/

Other AEs

 Urinary tract infection

Total

3

23.7% [13.5%, 35.5%]

0.0%

ADMSCs

1

21.4% [4.7%, 50.8%]

/

UCMSCs

1

25.0% [8.7%, 49.1%]

/

NSCs

1

24.1% [10.3%, 43.5%]

/

 Lung infection

Total

1

20.0% [5.7%, 43.7%]

/

UCMSCs

1

20.0% [5.7%, 43.7%]

/

 Pressure ulcer

Total

2

14.1% [5.2%, 25.8%]

0.0%

UCMSCs

1

10.0% [1.2%, 31.7%]

/

NSCs

1

17.2% [5.8%, 35.8%]

/

 Itching and rash

Total

2

1.6% [0.2%, 3.9%]

80.0%

BMSCs

1

14.3% [4.8%, 30.3]

/

ESCs

1

1.0% [0.1%, 3.5%]

/